Dual transgene expression in murine cerebellar Purkinje neurons by viral transduction in vivo

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Bosch, Marie K ^a   Nerbonne, Jeanne M ^a   Ornitz, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; FIBROBLAST GROWTH FACTOR 14; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR;

3' UNTRANSLATED REGION; ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; BRAIN FUNCTION; CAG REPEAT; CEREBELLUM CORTEX; CONTROLLED STUDY; DENDRITE; GENE EXPRESSION; GENE SEQUENCE; IMMUNOREACTIVITY; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; LENTIVIRINAE; LONG TERMINAL REPEAT; MOUSE; NERVE CELL; NONHUMAN; PERIKARYON; PLASMID; POLYADENYLATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PURKINJE CELL; REPORTER GENE; SEROTYPE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; WHITE MATTER; ANIMAL; C57BL MOUSE; CELL CULTURE; CEREBELLUM; CRICETULUS; CYTOLOGY; DEPENDOPARVOVIRUS; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HAMSTER; HEK293 CELL LINE; HUMAN; KNOCKOUT MOUSE; METABOLISM; PROCEDURES;

ANIMALS; CELLS, CULTURED; CEREBELLUM; CRICETINAE; CRICETULUS; DEPENDOVIRUS; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; HEK293 CELLS; HUMANS; LENTIVIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PURKINJE CELLS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 84905455206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104062     Document Type: Article

References (62)

1. Apps R, Garwicz M (2005) Anatomical and physiological foundations of cerebellar information processing. Nat Rev Neurosci 6: 297-311. (Pubitemid 40469984)
2. Manto M, Marmolino D (2009) Cerebellar ataxias. Curr Opin Neurol 22: 419-429.
3. Ramesh N, Kim ST, Wei MQ, Khalighi M, Osborne WR (1996) High-titer bicistronic retroviral vectors employing foot-and-mouth disease virus internal ribosome entry site. Nucleic Acids Res 24: 2697-2700. (Pubitemid 26239736)
4. Furler S, Paterna JC, Weibel M, Bueler H (2001) Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons. Gene Therapy 8: 864-873. (Pubitemid 32577191)
5. Gascon S, Paez-Gomez JA, Diaz-Guerra M, Scheiffele P, Scholl FG (2008) Dual-promoter lentiviral vectors for constitutive and regulated gene expression in neurons. Journal of Neuroscience Methods 168: 104-112.
6. Rendahl KG, Leff SE, Otten GR, Spratt SK, Bohl D, et al. (1998) Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol 16: 757-761. (Pubitemid 28363758)
7. Ngoi SM, Chien AC, Lee CG (2004) Exploiting internal ribosome entry sites in gene therapy vector design. Curr Gene Ther 4: 15-31. (Pubitemid 38854943)
8. de Felipe P, Luke GA, Hughes LE, Gani D, Halpin C, et al. (2006) E unum pluribus: multiple proteins from a self-processing polyprotein. Trends Biotechnol 24: 68-75. (Pubitemid 43151978)
9. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, et al. (2001) Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol 82: 1013-1025. (Pubitemid 32454602)
10. Shakkottai VG, Xiao M, Xu L, Wong M, Nerbonne JM, et al. (2009) FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons. Neurobiology of Disease 33: 81-88.
11. Xiao M, Bosch MK, Nerbonne JM, Ornitz DM (2013) FGF14 localization and organization of the axon initial segment. Mol Cell Neurosci 56: 393-403.
12. Van Swieten JC, Brusse E, De Graaf BM, Krieger E, Van De Graaf R, et al. (2003) A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia. Am J Hum Genet 72: 191-199. (Pubitemid 36056856)
13. Brusse E, de Koning I, Maat-Kievit A, Oostra BA, Heutink P, et al. (2006) Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): A new phenotype. Mov Disord 21: 396-401.
14. Dalski A, Atici J, Kreuz FR, Hellenbroich Y, Schwinger E, et al. (2005) Mutation analysis in the fibroblast growth factor 14 gene: frameshift mutation and polymorphisms in patients with inherited ataxias. Eur J Hum Genet 13: 118-120.
15. Misceo D, Fannemel M, Baroy T, Roberto R, Tvedt B, et al. (2009) SCA27 caused by a chromosome translocation: further delineation of the phenotype. Neurogenetics.
16. Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193-199.
17. Wang Q, Bardgett ME, Wong M, Wozniak DF, Lou J, et al. (2002) Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. Neuron 35: 25-38. (Pubitemid 34804320)
18. Zhang X, Baader SL, Bian F, Muller W, Oberdick J (2001) High level Purkinje cell specific expression of green fluorescent protein in transgenic mice. Histochem Cell Biol 115: 455-464. (Pubitemid 32662420)
19. Li M, Husic N, Lin Y, Christensen H, Malik I, et al. (2010) Optimal promoter usage for lentiviral vector-mediated transduction of cultured central nervous system cells. J Neurosci Methods 189: 56-64.
20. Ramezani A, Hawley TS, Hawley RG (2000) Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther 2: 458-469.
21. Klein RL, King MA, Hamby ME, Meyer EM (2002) Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Hum Gene Ther 13: 605-612. (Pubitemid 34264311)
22. Challita PM, Skelton D, el-Khoueiry A, Yu XJ, Weinberg K, et al. (1995) Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J Virol 69: 748-755.
23. Kobayashi H, Carbonaro D, Pepper K, Petersen D, Ge S, et al. (2005) Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector. Molecular Therapy 11: 776-789. (Pubitemid 40567982)
24. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471. (Pubitemid 28471781)
25. Stegmeier F, Hu G, Rickles RJ, Hannon GJ, Elledge SJ (2005) A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci U S A 102: 13212-13217. (Pubitemid 41325003)
26. Lou JY, Laezza F, Gerber BR, Xiao M, Yamada KA, et al. (2005) Fibroblast Growth Factor 14 is an Intracellular Modulator of Voltage-Gated Sodium Channels. Journal of Physiology 569: 179-193. (Pubitemid 41701384)
27. Kim JH, Lee SR, Li LH, Park HJ, Park JH, et al. (2011) High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One 6: e18556.
28. Li MJ, Rossi JJ (2007) Lentivirus transduction of hematopoietic cells. CSH Protoc 2007: pdb prot4755.
29. Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, et al. (2002) Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28: 158-167. (Pubitemid 35341079)
30. McEwen DP, Meadows LS, Chen C, Thyagarajan V, Isom LL (2004) Sodium channel beta1 subunit-mediated modulation of Nav1.2 currents and cell surface density is dependent on interactions with contactin and ankyrin. J Biol Chem 279: 16044-16049. (Pubitemid 38509293)
31. Manoonkitiwongsa PS, Schultz RL (2002) Proper nomenclature of formaldehyde and paraformaldehyde fixatives for histochemistry. Histochem J 34: 365-367. (Pubitemid 36543081)
32. Celio MR (1990) Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35: 375-475.
33. Alisky JM, Hughes SM, Sauter SL, Jolly D, Dubensky TW Jr, et al. (2000) Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 11: 2669-2673.
34. Kaemmerer WF, Reddy RG, Warlick CA, Hartung SD, McIvor RS, et al. (2000) In vivo transduction of cerebellar Purkinje cells using adeno-associated virus vectors. Mol Ther 2: 446-457.
35. Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, et al. (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10: 816-820. (Pubitemid 39070854)
36. Laezza F, Gerber BR, Lou JY, Kozel MA, Hartman H, et al. (2007) The FGF14(F145S) mutation disrupts the interaction of FGF14 with voltage-gated Na + channels and impairs neuronal excitability. J Neurosci 27: 12033-12044. (Pubitemid 350072101)
37. Tang W, Ehrlich I, Wolff SB, Michalski AM, Wolfl S, et al. (2009) Faithful expression of multiple proteins via 2A-peptide self-processing: a versatile and reliable method for manipulating brain circuits. J Neurosci 29: 8621-8629.
38. Kim JY, Ash RT, Ceballos-Diaz C, Levites Y, Golde TE, et al. (2013) Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuits in vivo. Eur J Neurosci 37: 1203-1220.
39. Wang Q, McEwen DG, Ornitz DM (2000) Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14. Mech Dev 90: 283-287. (Pubitemid 30042935)
40. Kordeli E, Lambert S, Bennett V (1995) AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier. J Biol Chem 270: 2352-2359.
41. Croci C, Fasano S, Superchi D, Perani L, Martellosio A, et al. (2006) Cerebellar neurons and glial cells are transducible by lentiviral vectors without decrease of cerebellar functions. Dev Neurosci 28: 216-221.
42. Takayama K, Torashima T, Horiuchi H, Hirai H (2008) Purkinje-cell- preferential transduction by lentiviral vectors with the murine stem cell virus promoter. Neurosci Lett 443: 7-11.
43. Torashima T, Okoyama S, Nishizaki T, Hirai H (2006) In vivo transduction of murine cerebellar Purkinje cells by HIV-derived lentiviral vectors. Brain Res 1082: 11-22.
44. Torashima T, Yamada N, Itoh M, Yamamoto A, Hirai H (2006) Exposure of lentiviral vectors to subneutral pH shifts the tropism from Purkinje cell to Bergmann glia. Eur J Neurosci 24: 371-380. (Pubitemid 44100329)
45. Goenawan H, Hirai H (2012) Modulation of lentiviral vector tropism in cerebellar Purkinje cells in vivo by a lysosomal cysteine protease cathepsin K. J Neurovirol 18: 521-531.
46. Kuroda H, Kutner RH, Bazan NG, Reiser J (2008) A comparative analysis of constitutive and cell-specific promoters in the adult mouse hippocampus using lentivirus vector-mediated gene transfer. J Gene Med 10: 1163-1175.
47. Jakobsson J, Ericson C, Jansson M, Bjork E, Lundberg C (2003) Targeted transgene expression in rat brain using lentiviral vectors. J Neurosci Res 73: 876-885. (Pubitemid 37071743)
48. Dittgen T, Nimmerjahn A, Komai S, Licznerski P, Waters J, et al. (2004) Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo. Proc Natl Acad Sci U S A 101: 18206-18211. (Pubitemid 40054098)
49. Delzor A, Dufour N, Petit F, Guillermier M, Houitte D, et al. (2012) Restricted transgene expression in the brain with cell-type specific neuronal promoters. Hum Gene Ther Methods.
50. Dodge JC, Clarke J, Song A, Bu J, Yang W, et al. (2005) Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease. Proc Natl Acad Sci U S A 102: 17822-17827. (Pubitemid 41803581)
51. Shearwin KE, Callen BP, Egan JB (2005) Transcriptional interference - a crash course. Trends Genet 21: 339-345. (Pubitemid 40726391)
52. Emerman M, Temin HM (1984) Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39: 449-467.
53. Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T (2000) IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1: 376-382.
54. Yu X, Zhan X, D'Costa J, Tanavde VM, Ye Z, et al. (2003) Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol Ther 7: 827-838. (Pubitemid 36790260)
55. Borman AM, Le Mercier P, Girard M, Kean KM (1997) Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res 25: 925-932. (Pubitemid 27298259)
56. Okubo Y, Kakizawa S, Hirose K, Iino M (2001) Visualization of IP(3) dynamics reveals a novel AMPA receptor-triggered IP(3) production pathway mediated by voltage-dependent Ca(2+) influx in Purkinje cells. Neuron 32: 113-122. (Pubitemid 32995894)
57. Ohashi Y, Tsubota T, Sato A, Koyano KW, Tamura K, et al. (2011) A bicistronic lentiviral vector-based method for differential transsynaptic tracing of neural circuits. Mol Cell Neurosci 46: 136-147.
58. de Felipe P, Luke GA, Brown JD, Ryan MD (2010) Inhibition of 2A-mediated 'cleavage' of certain artificial polyproteins bearing N-terminal signal sequences. Biotechnol J 5: 213-223.
59. Rothwell DG, Crossley R, Bridgeman JS, Sheard V, Zhang Y, et al. (2010) Functional expression of secreted proteins from a bicistronic retroviral cassette based on foot-and-mouth disease virus 2A can be position dependent. Hum Gene Ther 21: 1631-1637.
60. Yang S, Cohen CJ, Peng PD, Zhao Y, Cassard L, et al. (2008) Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Ther 15: 1411-1423.
61. Donnelly ML, Hughes LE, Luke G, Mendoza H, ten Dam E, et al. (2001) The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol 82: 1027-1041. (Pubitemid 32454603)
62. Szymczak-Workman AL, Vignali KM, Vignali DA (2012) Design and construction of 2A peptide-linked multicistronic vectors. Cold Spring Harb Protoc 2012: 199-204.